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ABSTRACT
Recombineering and multiplex automated genome
engineering (MAGE) offer the possibility to rapidly
modify multiple genomic or plasmid sites at high ef-
ficiencies. This enables efficient creation of genetic
variants including both single mutants with specifi-
cally targeted modifications as well as combinatorial
cell libraries. Manual design of oligonucleotides for
these approaches can be tedious, time-consuming,
and may not be practical for larger projects target-
ing many genomic sites. At present, the change
from a desired phenotype (e.g. altered expression
of a specific protein) to a designed MAGE oligo,
which confers the corresponding genetic change, is
performed manually. To address these challenges,
we have developed the MAGE Oligo Design Tool
(MODEST). This web-based tool allows designing
of MAGE oligos for (i) tuning translation rates by
modifying the ribosomal binding site, (ii) generat-
ing translational gene knockouts and (iii) introduc-
ing other coding or non-coding mutations, includ-
ing amino acid substitutions, insertions, deletions
and point mutations. The tool automatically designs
oligos based on desired genotypic or phenotypic
changes defined by the user, which can be used
for high efficiency recombineering and MAGE. MOD-
EST is available for free and is open to all users at
http://modest.biosustain.dtu.dk.
INTRODUCTION
Recombination-mediated genetic engineering (recombi-
neering) is readily applied for introduction of genetic vari-
ation in various organisms. Most often, longer inserts con-
taining selectablemarkers were previously used tomake one
genomic change at a time. The use of short, single-stranded
oligos has been shown to allow genomic modifications at
high efficiencies inEscherichia coli (1–3) and Saccharomyces
cerevisiae (4), thereby abolishing the need for a selectable
marker (1). This allows rapid generation of mutants with
specific changes and enables modification of many genomic
sites at once, e.g., bymultiplex automated genome engineer-
ing (MAGE) (1,5). These genome engineering methods are
fast and efficient, requiring only standard laboratory equip-
ment, for introducing simple mutations such as individual
gene knockouts and amino acid substitutions. The creation
of large cell libraries with targeted diversity can be achieved
using many different oligos at once and performing several
cycles of recombineering eithermanually orwith automated
approaches (1,4–5).
The experimental process is simple and involves (i) in-
duction of the recombineering system, (ii) preparation of
electrocompetent cells, (iii) addition of oligos and electro-
poration, and (iv) plating and identification of recombinant
clones using multiplex allele specific colony (MASC) poly-
merase chain reaction (PCR) (1,5). However, designing oli-
gos for recombineering and MAGE can be tedious, time-
consuming, and often leads to sub-optimal oligos in terms
of recombination efficiency. This can be a significant hin-
drance for implementation of multiplex genome engineer-
ing and makes larger scale projects, involving modifications
of many targets, impractical or even impossible (e.g. for sev-
eral thousand oligos).
In this study, we present MODEST, a web server for au-
tomatic design of optimized oligos, for recombineering and
MAGE. The user can specify the desired mutations in a va-
riety of input formats, and MODEST will design and opti-
mize oligos, thereby introducing the desired genetic change
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(Figure 1). Target genomes are selected from a list, auto-
matically loaded into the web server from NCBI by en-
tering a genbank ID, or uploaded as a genbank file. The
user can specify positions and desired mutations in drop-
down menus and text fields, select specific genes, or provide
a DNA sequence, including an indication of modifications.
MAGE oligos are designed on the basis of the specified
genetic change and are subsequently optimized. The opti-
mization process involves shifting the location of the muta-
tion within the oligo while evaluating the self-folding energy
of the oligo. The oligo with the highest self-folding energy,
where themutations are at least 15 bp away from each end, is
selected to avoid loss of the genetic change because of oligo
processing by exonucleases (1,6–7).
Several modules are built on top of the oligo creation rou-
tine. The gene knockout module identifies putative muta-
tions that should create a stable knockout of a gene by in-
troducing several tandem stop codons. The translation rate
module allows the user to specify a desired translation rate
or set of translation rates, andMODEST will calculate mu-
tations to achieve this with the least number of modifica-
tions. For this module, we developed aMonte Carlo simula-
tion coupled with evaluation of translation rates based on a
prediction algorithm previously developed (8). A visualiza-
tion of the designedMAGE oligos and achieved expression
level for each oligo versus the wild-type level is provided in
the output.
A successful allelic replacement can be verified through
MASC PCR and gel electrophoresis. MODEST automat-
ically designs MASC PCR primers for PCR products of
different lengths that can be used to identify mutant and
wild-type colonies by employing different forward primers
specific for the mutant and wild-type sequence, respectively
(5).
Oligos created with MODEST are optimal for use with
MAGE and recombineering methods where the methyl-
directed mismatch repair (MMR) system is unfunctional,
e.g., by using aMutSmutant strain (1) or a systemwhere the
MMR system can be temporarily knocked out (9). Sawitzke
et al. (6) points out that the MMR system can be avoided
by adding multiple specific changes in an oligo, and we are




The input format for full organism sequences is an anno-
tated GenBank file. The MODEST web server defaults to
E. coli K12 MG1655. Other genomes can be used by ei-
ther uploading a GenBank file or entering a GenBank se-
quence accession number for MODEST to automatically
download. MODEST requires additional information on
the target genome that is not available from the GenBank
file, namely the replication origin and terminus, to design
MAGE oligos targeting the lagging strand of DNA replica-
tion (6,10). This information can be supplied via the web in-
terface or as a file upload. The parsing and automatic fetch-
ing of GenBank files is handled by the Biopython package
(11). Bacterial genomes are fully supported at this time, but
eukaryotic chromosomes and multiple origins are not. We
plan to add this functionality in a future update.
The genomic changes are input as a white-space sepa-
rated file, which can be dynamically created through theweb
interface, pasted onto the web interface, or uploaded.When
a target genome is selected using theweb server, the dynamic
interface will automatically load the annotated genes and
display them alongwith the availableMODEST operations.
When a gene or an operation is selected in the menu, rel-
evant information such as gene sequence, documentation,
and examples are loaded onto the sidebar.
Oligo design and optimization
When a job is submitted, including specification of tar-
get genome and desired modifications, MODEST performs
module-specific operations and returns a mutation object.
The simplest available operation applies the mutation mod-
ule, which accepts a desired nucleotide mutation, verifies
it, and returns a mutation object. More complex modules
include the gene knockout and translation rate modules.
The internals ofMODEST include a framework designed to
rapidly expand and program new modules without chang-
ing the MODEST internals or the web server.
After a list of mutation objects is created, it is passed to
the oligo creation and optimization routine. This routine ex-
tracts a length of nucleotides from the genomic sequence,
upstream and downstream of the mutation target site, to
obtain a full-length oligo based on user preference. Some
studies have found 90 bp oligos to be optimal when cost
is disregarded (1), while others have found shorter oligos
of 60–70 bp to be equally efficient (6). The desired oligo
length is a balance between targeting efficiency, cost of syn-
thesis, and error rate of oligos (which is higher for longer
oligos), and thus depends largely on individual preferences
and future expanded studies. We therefore set the default
oligo length for MODEST to 90 bp, but with a possibility
to easily change it under the advanced options at the web
server.
If necessary, the sequence is reverse complemented to tar-
get the lagging strand (3). To perform this operation, the lo-
cation of the oligo is determined relative to the known ori-
gin and terminus of replication. Commonly used genomes
with annotated or predicted origin and terminus of replica-
tion is available directly inMODEST and listed with details
and corresponding methods for recombination with single-
stranded oligos (12–15) in Table 1. MODEST can automat-
ically detect annotated origin of replication as is the case
for E. coli K12 MG1655. For other genomes, the DoriC
database (16) provides the sites of replication initiation. If
no termination information is available, the site is estimated
to be near the dif site, or on the opposite side of the circular
genome. Replication does not necessarily terminate at the
dif sites, but it provides a good approximation (17). Origin
and termini can also be entered manually when specifying
a new genome by selecting ‘other’ in the ‘Choose an organ-
ism’ menu.
Another important parameter for oligo optimization is to
avoid the formation of stable and closed secondary DNA
structures, which will negatively affect the recombineering
efficiency (5). MODEST predicts DNA folding by calcu-
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Figure 1. Concept flowchart of MODEST. The user selects or supplies an annotated genome along with a specification of the desired mutations, i.e.
insertions, deletions, point mutations and amino acid substitutions, or phenotypic changes such as changes in the rate of protein translation and gene
knockouts. MODEST processes this into a list of mutation objects, which are passed to an oligo design and optimization routine. This results in the design
of MAGE oligos, MASC PCR primers, a report, and visualization of results.
Table 1. Overview of origin of replication and terminus region for strains wheremethods for recombinationwith single-stranded oligos have been developed




Escherichia coli str. K-12
substr. MG1655
3923767..3923998 1339769..1682272 NC 000913 ssOligo method: (5) oriC: annotated in
GenBank Termini: (12)
Salmonella typhimurium LT2 4083788..4084165 1629676..1629703 NC 003197 ssOligo method: (13) oriC: (16) Termini:a
Pseudomonas syringae str.
DC3000
1..338 3211773..3211800 NC 004578 ssOligo method: (13) oriC: (16) Termini:a
Lactobacillus plantarum
WCFS1
1369..1545 1655121..1655148 NC 004567 ssOligo method: (14) oriC: (16) Termini:a
Lactobacillus reuteri F275 1324..1498 1021118 NC 010609 ssOligo method: (14) oriC: (16) Termini:b
Pantoea ananatis AJ13355 3803155..3803586 1523700..1523727 NC 017531 ssOligo method: (15) oriC: (16) Termini:a
aEstimated as being near the dif site.
bEstimated as being near the opposite side of the genome.
lating the minimum free energy of the secondary structure
of the oligo by employing the fold program from the Vien-
naRNA package (18). The oligo frame is shifted along the
genome to find the configuration with the highest minimum
free energy. A total of 15 bp of homology is retained at each
end of the oligo to prevent decreased integration efficiency
because of DNA processing (Figure 2) (19). If desired, op-
timization of secondary structure can be disabled in the ad-
vanced settings, which will result in oligos where mutations
are centered.
MASC primers
MASC PCR is a technique for rapidly assessing the pres-
ence of a specific allele (5). For each analyzed locus, three
primers are designed: two different forward primers, one
specific for the wild-type sequence (fwwt) and one specific
to the mutated sequence (fwmut), and one universal reverse
primer. By determining which forward primer leads to the
generation of a PCR product in colony PCRs, mutant and
wild-type colonies can easily be identified.
MODEST creates MASC primers based on the designed
mutations. The algorithm for design of the MASC primers
starts at the 3′-end of the wild-type and mutated sequence.
From this position, nucleotides are added in the upstream
direction until a melting temperature of 62◦C (5) of the
primer is reached. The melting temperature is calculated
with the method described in (20). The fwmut and fwwt
primers are then checked to ensure that they are not iden-
tical. If they are, the primer design frame is shifted one nu-
cleotide downstream and the process is repeated. This en-
sures that the two primers generated by the algorithm will
only hybridize with either the wild-type ormutant sequence.
The output is in the form of a table with a reference to
each oligo via an ID, forward primers for the wild-type and
mutant, and a list of reverse primers producing 10 PCR am-
plicons of different length (100, 150, 200, 250, 300, 400, 500,
600, 700 and 850 bp, respectively). This allows the user to
select primer pairs to produce amplicons of a desired size,
which facilitatesmixing ofmultiple primer sets that produce
different size amplicons in the same MASC PCR reaction.
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Figure 2. Optimization of oligos to increase recombination efficiency. (A) Optimization of the secondary structure of the oligo to avoid high energy
secondary structures in the oligo (frame 1). The frame of the oligo is changed to achieve the lowest energy secondary structure (frame 2) with the highest
minimum free energy (mfe) possible, within the limitation that the mutation has to be at least 15 bp from the end of the oligo. (B) The highest efficiency is
achieved when targeting the lagging strand. Therefore, oligos that target the leading strand are reverse complemented.
Designing oligos for translational gene knockouts
Gene knockouts are traditionally created by complete dele-
tion of the coding sequence. This option is available in
MODEST by choosing the delete function. However, re-
placement or deletion of entire genes is known to have low
efficiencies using genome engineering without selectable
markers (5). To address the problem with low recombi-
neering efficiencies when introducing large genetic modifi-
cations, we developed an alternative option to create trans-
lational gene knockouts that combine high recombineer-
ing efficiency with the phenotypic stability of a deletion
mutant (1). The translational gene knockout operation de-
signs oligos that will introduce tandem stop codons in the
first half of the gene sequence. By introducing tandem stop
codons, the probability of restoring gene function by acqui-
sition of reverse mutations is drastically reduced because all
stop codons need to be simultaneously reverted. The tan-
dem stop codons are also designed to include all three types
of stop codons to abolish the possibility of restoring gene
function via the acquisition of tRNA suppressor mutations
(21). By localizing the mutations to the first half of the gene,
the likelihood of producing a truncated protein with some
residual activity is minimized.
The default values are three different stop codons in the
first half of the gene. To achieve the highest recombineering
frequency, a brute-force scoring scheme is used, where every
possibility of each stop codon for every position is calcu-
lated (Figure 3A). A matrix of how many mutations are re-
quired by each codon to mutate into each stop codon is cal-
culated, and a window with the desired number of consecu-
tive stop codons (e.g. three) is then slid along the sequence
to calculate the number of mutations required for each win-
dow (set of codons). The set of codons that require the
fewest mutations are then selected, and if more are present
with the same score, the one closest to the start of the gene
is preferred. We used the algorithm to design knockout oli-
gos for all genes in E. coli. Interestingly, most non-essential
genes inE. coli are predicted to be efficiently knocked out by
this approachwith as little as three or four nucleotide substi-
tutions (Figure 3B). The expected replacement efficiency for
introducing any gene knockout in a non-essential gene can
be calculated to be between 11.6% (seven mutations) and
19.8% (threemutations) (5). Using this method, as few as 5–
10 colonies will have to be screened after MAGE to identify
a successful knockout, without using any selection marker.
Essential genes will be knocked out with greatly reduced ef-
ficiency, and only occurs in cells that contain a naturally oc-
curring duplication of the region of interest (22). However,
we used all genes in the calculation to not exclude any genes
that may be essential only in specific environments (23,24).
Creating oligos that modulate the translation rate of a target
gene
Modulation of expression level to increase the flux to a given
metabolite is a key goal in metabolic engineering, but most
often only a few predicted targeted modifications can be
tested because of practical limits. The sequence of the 5′ un-
translated region (5′ UTR), including the ribosome binding
site, greatly influences the expression level of a gene (25–
28). Wang et al. have shown that modulating protein ex-
pression with degenerate MAGE oligos, targeting the Ri-
bosome Binding Site (RBS) of 20 different genes, resulted
in radically improved lycopene production (1). However, by
this approach, most of the applied oligos are redundant, i.e.
they achieve similarly low expression levels. This reduces the
phenotypic space that can be explored since only a small
fraction of the applied oligos will be functional with respect
tomodulating protein expression levels. High-quality cell li-
braries with many combinations of genomic changes can be
constructed by predicting and introducing precise changes
estimated to result in desired levels of expression.
Salis et al. have developed an algorithm for predicting
protein expression based on thermodynamic calculations
of the 5′ UTR and gene sequence (8). We used this pre-
diction algorithm as a basis for identifying gene sequences
resulting in desired expression levels and that could be ob-
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Figure 3. Changes in gene expression by gene knockouts and mutations in the ribosomal binding site. (A) Translational knockout module to predict
effective knockouts with the fewest number of mutations. The translational gene knockout algorithm works as follows. (1) Calculate matrix of how many
mutations are required by each codon to mutate into each stop codon. (2) Calculate the combination containing each stop codon with the least amount
of mutations for the chosen window. (3) Slide window along the sequence and calculate best combination for each codon position. (4) Choose a codon
position with the least number of mutations and mutate sequence (green: start codon, shades of red: stop codons). (B) The theoretical number of mutations
required to create translational knockouts by producing three consecutive different stop codons in the first half of the gene was calculated for all genes in E.
coli. Essential genes cannot be knocked out by this approach. (C) Overview of the Monte Carlo simulation that alters the ribosomal binding site sequence
through random mutations over several iterations: (1) prediction of expression level for new sequence based on an RBS calculator (8); (2) evaluation of
predicted expression level compared to previously evaluated sequence; (3a) sequences with higher performance are always accepted; (4a) sequences with a
lower expression are accepted based on a weighted probability; (4b) some are rejected based on a weighted probability. (D) A visual overview of the multiple
Monte Carlo passes used to target the highest possible predicted expression level. The red line shows the translational expression level in arbitrary units
(AU), the dark blue line shows the virtual temperature parameter, and the light blue bars are the probability that a new mutation with a lower predicted
expression is accepted.
tained with as few nucleotide substitutions as possible. Be-
cause the total number of possible gene sequences that may
result in changed expression is too large for calculations
within practical time limits, we developed a Monte Carlo
simulated annealing method that alters the ribosomal bind-
ing site sequence through random mutations over several
iterations. For each round, a random position is mutated
and the expression of the mutant is scored by calculating
the Gibbs free energy change for translation initiation with
the algorithm developed by Salis et al. (8). The new mu-
tant is selected based on performance and random chance
via the standard Metropolis criterion. A mutation is con-
sidered better performing when the predicted expression is
closer to target expression than the current best candidate.
This mutation is accepted as the new best candidate, and
all future mutations are based on the best candidate. If the
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new mutant performs worse than the original best candi-
date, an acceptance probability is calculated on the basis of
the difference between original and new mutant and a ‘vir-
tual temperature’ parameter. The newmutation is randomly
accepted as the new best with the calculated probability or
rejected, and the original mutation is kept as the best candi-
date. The simulation starts in a ‘hot’ phase where the tem-
perature parameter is high, which means that the probabil-
ity of an acceptance is high, and then gradually cools down
until the likelihood of acceptance is based solely on perfor-
mance. The hot-phase step is used to avoid local minima.
The temperature and probability is visualized in Figure
3D, which shows the increasing expression level as the sim-
ulation proceeds. As the temperature drops during a pass,
the average probability decreases alongside. The whole sim-
ulation is implemented in a number of passes, each with sev-
eral rounds. In the first pass, only one mutation is allowed.
If this fails to reach the defined target expression level, an
additional mutation is allowed using the previous mutation
as the starting point. Another mutation is then allowed un-
til the target expression level or a user-specified limitation
is reached (e.g. the parameter max mutations = 5 limits the
number of mutated bases to 5). The beginning of a new pass
can be seen in Figure 3D each time the temperature jumps
to a new starting temperature. The optimal starting temper-
ature for a number of mutations is automatically estimated.
In case of the 5′ UTR of the targeted gene overlapping
the coding sequence of an upstream gene, the RBS module
is restricted to only allow wobble sequences that are auto-
matically detected to prevent undesirable amino acid sub-
stitutions in the upstream gene.
Users can generate RBS libraries, consisting of several
different oligos with different target expression levels, by
specifying a parameter (e.g. n = 10) to the operation. To
achieve a broad range of expression levels, the algorithm
aims to collect sequences where the predicted expression
level fits an exponential distribution. The operation outputs
a list of mutation objects, which is processed by the oligo
creation routine and output as optimized MAGE oligos.
Barcoding of oligos for MO-MAGE
Microarray oligonucleotide MAGE (MO-MAGE) is a
novel method to amplify and process oligos from microar-
ray chips for direct use inMAGE to simultaneously perturb
thousands of genomic sites (29). Barcoding refers to addi-
tion of 20 bp sequences at each end of an oligo suitable for
performing PCR. Specific subpools of oligos can be bar-
coded with unique sequences to allow selective amplifica-
tion of a subpool from a complex pool of oligos (e.g. several
thousands) synthesized on microarrays. The oligos are sub-
sequently enzymatically processed to remove the barcodes.
MODEST supports MO-MAGE by allowing the addition
of barcodes to individually designed oligos. Oligos can be
barcoded by providing a unique barcoding ID when speci-
fying the oligo design. The barcoding ID refers to specific
sets of sequences that will be added to each end of the de-
signed oligos. The default barcoding sequences are based
on 20 primer sets optimized to avoid cross priming to other
barcodes or the E. coli genome (30). It is also possible to
provide a custom barcoding table in the advanced options
by pasting or uploading a text file.
EXAMPLE
To illustrate the use of MODEST, we have created a simple
example where the user desires to create several clones with
various levels of increased expression of lacZ in the genome
encoding beta-galactosidase. The user wants to design a li-
brary of 10 oligos that increases expression level of lacZ to
different levels, one knockout and five oligos downregulat-
ing lacI (encoding a repressor of lacZ) and four oligos up-
regulating as well as four oligos downregulating crp (encod-
ing cAMP receptor protein, which activates transcription of
lacZ). The goal is to obtain a library of clones with different
expression levels of lacZ.
The user supplies a project name and specifies the ap-
propriate genome either by using a genome already on the
server, by uploading a GenBank file, or supplying a Gen-
Bank identifier. When an external genome is used, the user
must also specify the origin and terminus of replication or
supply an already generated corresponding genome config-
uration file. The user then selects the desired target (spe-
cific gene or the genome) and desired alteration, resulting
in automatic generation of an input file. The generated in-
put file can be manually edited and downloaded for refer-
ence or later use. Advanced options can be used to specify
non-default oligo length or provide barcoding sequences, if
desired. In this example, the default options are used (90 bp
oligos, no barcoding).
When the user clicks ‘submit’, the job is started, and a log
is displayed and dynamically updated for the user to follow
the progression of the job. When the job is completed, the
results page appears, stating that the job was successfully
completed or any warnings or errors. The designed oligos
are shown in a table and can be easily copied to the order-
ing form format of most commercial suppliers. The user can
also access theMASC PCR primers and choose primer sets
corresponding to a desired fragment length. All files includ-
ing input and configuration files as well as output files in a
spreadsheet format can be downloaded as a zip file. Oligos
designed to change the expression level of a gene are visu-
alized as shown in Figure 4 to provide a graphical overview
of the results.
CONCLUSION
MODEST provides a platform for automatic design of oli-
gos for MAGE and recombineering and is designed for the
ease of use for researchers without programming experi-
ence. The web server is freely available at http://modest.
biosustain.dtu.dk and offers the possibility for automatic
oligo design based on user specification of a target genome,
a list of desired genomic modifications, or desired pheno-
typic result such asmodified gene expression or gene knock-
outs. The server will be useful for simpler projects employ-
ing recombineering with a few oligos and complex projects
involving hundreds of oligos or even thousands with the
built-in support of MO-MAGE (29). The tool significantly
reduces the time needed for genome engineering projects
and enables broader implementation ofMAGE by lowering
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Figure 4. Example of MODEST output, showing a visualization of the
insilico calculated translation rates expected to result from the mutations
in the designed oligos. The light green bar is the predicted wild-type ex-
pression level, and the dark green bar is the maximum achieved expression
level. The black/gray arrows denote the expression level of the designed
oligos.
the barrier to get started with a new technique. MODEST
will also provide a framework for more advanced projects
where oligo design is impossible to perform manually.
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